Target Name: KIAA1755
NCBI ID: G85449
Other Name(s): quo | KIAA1755, transcript variant 1 | KIAA1755 variant 1 | K1755_HUMAN | quattro homolog | RP5-1054A22.3 | Uncharacterized protein KIAA1755 | Uncharacterized protein KIAA1755 (isoform a)

KIAA1755: A Potential Drug Target for Various Diseases

KIAA1755 is a protein that is expressed in most tissues of the body and is involved in various cellular processes such as cell adhesion, migration, and invasion. It is a member of the integrin receptor family, which is a large family of transmembrane proteins that play a crucial role in cell-cell interactions and tissue organization.

Recent studies have identified KIAA1755 as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these diseases has been attributed to its involvement in the regulation of cellular processes that are disrupted in these conditions.

One of the key mechanisms by which KIAA1755 is involved in disease is its role in the regulation of cell-cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. In cancer, this process can be disrupted, leading to the development of cancer cells. KIAA1755 has been shown to play a role in regulating cell-cell adhesion by controlling the activity of integrins, which are proteins that help cells stick together.

In addition to its role in cell-cell adhesion, KIAA1755 has also been shown to be involved in the regulation of cell migration. Migration is the process by which cells move from one location to another in the body. In cancer, this process can be disrupted, leading to the development of cancer cells. KIAA1755 has been shown to play a role in regulating cell migration by controlling the activity of motors, which are proteins that help cells move.

KIAA1755 has also been shown to be involved in the regulation of inflammation. Inflammation is a natural response of the immune system to injury or infection. However, chronic inflammation can lead to a range of diseases, including cancer and neurodegenerative diseases. KIAA1755 has also been shown to play a role in regulating inflammation by controlling the activity of immune cells and promoting the production of anti-inflammatory cytokines.

In conclusion, KIAA1755 is a protein that is involved in various cellular processes that are disrupted in a wide range of diseases. Its role in these processes makes it a potential drug target for cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of KIAA1755 in these diseases and to develop effective treatments.

Protein Name: KIAA1755

More Common Targets

KIAA1958 | KIAA2012 | KIAA2013 | KIAA2026 | KICS2 | KIDINS220 | KIF11 | KIF12 | KIF13A | KIF13B | KIF14 | KIF15 | KIF16B | KIF17 | KIF18A | KIF18B | KIF19 | KIF1A | KIF1B | KIF1C | KIF20A | KIF20B | KIF21A | KIF21B | KIF22 | KIF23 | KIF23-AS1 | KIF24 | KIF25 | KIF25-AS1 | KIF26A | KIF26B | KIF27 | KIF28P | KIF2A | KIF2B | KIF2C | KIF3A | KIF3B | KIF3C | KIF4A | KIF4B | KIF5A | KIF5B | KIF5C | KIF6 | KIF7 | KIF9 | KIF9-AS1 | KIFAP3 | KIFBP | KIFC1 | KIFC2 | KIFC3 | Killer Cell Immunoglobulin-Like Receptor (KIR) | Killer cell immunoglobulin-like receptor 2DS1, transcript variant X1 | KIN | Kinesin-like protein KIF16B (isoform 1) | KIR2DL1 | KIR2DL2 | KIR2DL3 | KIR2DL4 | KIR2DL5A | KIR2DL5B | KIR2DP1 | KIR2DS1 | KIR2DS2 | KIR2DS3 | KIR2DS4 | KIR2DS5 | KIR3DL1 | KIR3DL2 | KIR3DL3 | KIR3DP1 | KIR3DS1 | KIR3DX1 | KIRREL1 | KIRREL1-IT1 | KIRREL2 | KIRREL3 | KIRREL3-AS2 | KIRREL3-AS3 | KISS1 | KISS1R | KIT | KITLG | KIZ | KIZ-AS1 | KL | KLB | KLC1 | KLC2 | KLC3 | KLC4 | KLF1 | KLF10 | KLF11 | KLF12 | KLF13 | KLF14